Literature DB >> 27733690

Totally Percutaneous Aneurysm Sac Embolization During Endovascular Aneurysm Repair.

Luca Ferretto1, Sandro Irsara1.   

Abstract

PURPOSE: To describe a sac embolization technique modification for type II endoleak prevention that makes a totally percutaneous approach feasible during endovascular aneurysm repair (EVAR) using the Excluder stent-graft. TECHNIQUE: Percutaneous access of the common femoral arteries is obtained and 2 suture-mediated closure systems are placed on each side. A 16-F or 18-F sheath is placed for delivery of the Excluder stent-graft main body and a 16-F sheath is used on the contralateral side. After the stent-graft and contralateral limb component are delivered to their intended positions, a standard 0.035-inch hydrophilic guidewire is placed into the aneurysm sac through the same 16-F sheath. Then a 5-F, straight, 65-cm-long catheter is advanced over the standard wire into the sac in parallel with the contralateral limb. The contralateral limb is deployed, the standard guidewire is removed; coils are released through the 5-F catheter into the sac, followed by injection of 5 to 10 mL of double-component fibrin glue.
CONCLUSION: Totally percutaneous, nonselective sac embolization during EVAR, with a single access on each femoral artery, is feasible and helpful to physicians who wish to perform intraoperative sac embolization without relevant changes in their usual EVAR procedure.

Entities:  

Keywords:  abdominal aortic aneurysm; aneurysm sac embolization; endovascular aneurysm repair; intrasac embolization; percutaneous embolization; type II endoleak

Mesh:

Year:  2016        PMID: 27733690     DOI: 10.1177/1526602816674212

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  1 in total

1.  A simplified method of pre-emptive perigraft aortic sac embolization to prevent type II endoleak using the Excluder endograft.

Authors:  Brendon Reilly; Mariel Rivero; Hasan H Dosluoglu
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.